These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17149863)

  • 1. Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
    Leon A; Liu L; Yang Y; Hudock MP; Hall P; Yin F; Studer D; Puan KJ; Morita CT; Oldfield E
    J Med Chem; 2006 Dec; 49(25):7331-41. PubMed ID: 17149863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations.
    Ling Y; Sahota G; Odeh S; Chan JM; Araujo FG; Moreno SN; Oldfield E
    J Med Chem; 2005 May; 48(9):3130-40. PubMed ID: 15857119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures of a potent phenylalkyl bisphosphonate inhibitor bound to farnesyl and geranylgeranyl diphosphate synthases.
    Cao R; Chen CK; Guo RT; Wang AH; Oldfield E
    Proteins; 2008 Nov; 73(2):431-9. PubMed ID: 18442135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.
    Sanders JM; Ghosh S; Chan JM; Meints G; Wang H; Raker AM; Song Y; Colantino A; Burzynska A; Kafarski P; Morita CT; Oldfield E
    J Med Chem; 2004 Jan; 47(2):375-84. PubMed ID: 14711309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption.
    Sanders JM; Song Y; Chan JM; Zhang Y; Jennings S; Kosztowski T; Odeh S; Flessner R; Schwerdtfeger C; Kotsikorou E; Meints GA; Gómez AO; González-Pacanowska D; Raker AM; Wang H; van Beek ER; Papapoulos SE; Morita CT; Oldfield E
    J Med Chem; 2005 Apr; 48(8):2957-63. PubMed ID: 15828834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the response of Escherichia coli to fosfomycin and fosmidomycin.
    Kanimoto Y; Greenwood D
    Eur J Clin Microbiol; 1987 Aug; 6(4):386-91. PubMed ID: 3311734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of insect isoprenoid biosynthesis with pyridinium bisphosphonates.
    Sen SE; Wood L; Jacob R; Xhambazi A; Pease B; Jones A; Horsfield T; Lin A; Cusson M
    Insect Biochem Mol Biol; 2015 Aug; 63():113-23. PubMed ID: 26073627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallographic structures of two bisphosphonate:1-deoxyxylulose-5-phosphate reductoisomerase complexes.
    Yajima S; Hara K; Sanders JM; Yin F; Ohsawa K; Wiesner J; Jomaa H; Oldfield E
    J Am Chem Soc; 2004 Sep; 126(35):10824-5. PubMed ID: 15339150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses and characterization of non-bisphosphonate quinoline derivatives as new FPPS inhibitors.
    Liu J; Liu W; Ge H; Gao J; He Q; Su L; Xu J; Gu LQ; Huang ZS; Li D
    Biochim Biophys Acta; 2014 Mar; 1840(3):1051-62. PubMed ID: 24246954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase.
    Wiemer AJ; Tong H; Swanson KM; Hohl RJ
    Biochem Biophys Res Commun; 2007 Feb; 353(4):921-5. PubMed ID: 17208200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.
    Kuntz L; Tritsch D; Grosdemange-Billiard C; Hemmerlin A; Willem A; Bach TJ; Rohmer M
    Biochem J; 2005 Feb; 386(Pt 1):127-35. PubMed ID: 15473867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for bisphosphonate-mediated inhibition of isoprenoid biosynthesis.
    Hosfield DJ; Zhang Y; Dougan DR; Broun A; Tari LW; Swanson RV; Finn J
    J Biol Chem; 2004 Mar; 279(10):8526-9. PubMed ID: 14672944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of defense responses in Escherichia coli treated with fosmidomycin.
    Hemmerlin A; Tritsch D; Hammann P; Rohmer M; Bach TJ
    Biochimie; 2014 Apr; 99():54-62. PubMed ID: 24262605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of sulfonium bisphosphonates on tumor cell lines.
    Zhang Y; Hudock MP; Krysiak K; Cao R; Bergan K; Yin F; Leon A; Oldfield E
    J Med Chem; 2007 Nov; 50(24):6067-79. PubMed ID: 17963374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Activity between Statins and Bisphosphonates against Acute Experimental Toxoplasmosis.
    Li ZH; Li C; Szajnman SH; Rodriguez JB; Moreno SNJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-state NMR, crystallographic, and computational investigation of bisphosphonates and farnesyl diphosphate synthase-bisphosphonate complexes.
    Mao J; Mukherjee S; Zhang Y; Cao R; Sanders JM; Song Y; Zhang Y; Meints GA; Gao YG; Mukkamala D; Hudock MP; Oldfield E
    J Am Chem Soc; 2006 Nov; 128(45):14485-97. PubMed ID: 17090032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights about the structure of farnesyl diphosphate synthase (FPPS) and the activity of bisphosphonates on the proliferation and ultrastructure of Leishmania and Giardia.
    Gadelha APR; Brigagao CM; da Silva MB; Rodrigues ABM; Guimarães ACR; Paiva F; de Souza W; Henriques C
    Parasit Vectors; 2020 Apr; 13(1):168. PubMed ID: 32248823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation.
    Wiemer AJ; Yu JS; Shull LW; Barney RJ; Wasko BM; Lamb KM; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2008 Apr; 16(7):3652-60. PubMed ID: 18308574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosmidomycin resistance in adenylate cyclase deficient (cya) mutants of Escherichia coli.
    Sakamoto Y; Furukawa S; Ogihara H; Yamasaki M
    Biosci Biotechnol Biochem; 2003 Sep; 67(9):2030-3. PubMed ID: 14519998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of a series of aromatic bisphosphonates.
    Barney RJ; Wasko BM; Dudakovic A; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2010 Oct; 18(20):7212-20. PubMed ID: 20832326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.